We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation.
- Authors
Enyedi, Enikő E.; Petukhov, Pavel A.; Kozuch, Alexander J.; Dudek, Steven M.; Toth, Attila; Fagyas, Miklós; Danilov, Sergei M.
- Abstract
Angiotensin-converting enzyme (ACE) metabolizes a number of important peptides participating in blood pressure regulation and vascular remodeling. Elevated ACE expression in tissues (which is generally reflected by blood ACE levels) is associated with an increased risk of cardiovascular diseases. Elevated blood ACE is also a marker for granulomatous diseases. Decreased blood ACE activity is becoming a new risk factor for Alzheimer's disease. We applied our novel approach—ACE phenotyping—to characterize pairs of tissues (lung, heart, lymph nodes) and serum ACE in 50 patients. ACE phenotyping includes (1) measurement of ACE activity with two substrates (ZPHL and HHL); (2) calculation of the ratio of hydrolysis of these substrates (ZPHL/HHL ratio); (3) determination of ACE immunoreactive protein levels using mAbs to ACE; and (4) ACE conformation with a set of mAbs to ACE. The ACE phenotyping approach in screening format with special attention to outliers, combined with analysis of sequencing data, allowed us to identify patient with a unique ACE phenotype related to decreased ability of inhibition of ACE activity by albumin, likely due to competition with high CCL18 in this patient for binding to ACE. We also confirmed recently discovered gender differences in sialylation of some glycosylation sites of ACE. ACE phenotyping is a promising new approach for the identification of ACE phenotype outliers with potential clinical significance, making it useful for screening in a personalized medicine approach.
- Subjects
BIBLE. Revelation; ANGIOTENSIN I; ACE inhibitors; DISEASE risk factors; REGULATION of blood pressure; ANGIOTENSIN converting enzyme; BIOCHEMICAL substrates; MEDICAL screening
- Publication
Biomedicines, 2024, Vol 12, Issue 5, p940
- ISSN
2227-9059
- Publication type
Article
- DOI
10.3390/biomedicines12050940